Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin-Reference-Cited by-同舟云学术

Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin

Published:2017-06-22 Issue:7 Volume:18 Page:1333
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Chang Cara,Hu Yichun,Hogan Susan,Mercke Nickie,Gomez Madeleine,O’Bryant Cindy,Bowles Daniel,George Blessy,Wen Xia,Aleksunes Lauren,Joy Melanie

Funder

National Institutes of Health

National Institute of Environmental Health Sciences

American Foundation for Pharmaceutical Education

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/7/1333/pdf

Reference57 articles.

1. Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.

2. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

3. Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer

4. Phase II Feasibility Study of Sequential Couplets of Cisplatin/Topotecan Followed by Paclitaxel/Cisplatin as Primary Treatment for Advanced Epithelial Ovarian Cancer: A National Cancer Institute of Canada Clinical Trials Group Study

5. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The toxicity of cisplatin derives from effects on renal organic ion transporters expression and serum endogenous substance levels;Food and Chemical Toxicology;2024-10

2. Development and validation of a LASSO prediction model for cisplatin induced nephrotoxicity: a case-control study in China;BMC Nephrology;2024-06-11

3. Development and Validation of a LASSO Prediction Model for cisplatin induced nephrotoxicity: A Case-Control Study in China;2023-10-31

4. Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy;International Journal of Molecular Sciences;2023-06-07

5. Polymorphic renal transporters and cisplatin’s toxicity in urinary bladder cancer patients: current perspectives and future directions;Medical Oncology;2023-01-17